SEARCH

SEARCH BY CITATION

References

  • 1
    Chabriat H, Mrissa R, Levy C et al. Brain stem MRI signal abnormalities in CADASIL. Stroke 1999; 30:4579.
  • 2
    de Leeuw FE, de Groot JC, Achten E et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70:914.
  • 3
    Fazekas F, Kleinert R, Offenbacher H et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43:16839.
  • 4
    Breteler MM, van Swieten JC, Bots ML et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994; 44:124652.
  • 5
    Firbank MJ, Wiseman RM, Burton EJ, Saxby BK, O'Brien JT, Ford GA. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol 2007; 254:71321.
  • 6
    Jeerakathil T, Wolf PA, Beiser A et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004; 35:185761.
  • 7
    O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001; 56:62834.
  • 8
    Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's Dementia and Normal Aging. AJNR Am J Neuroradiol 1986; 149:3516.
  • 9
    O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, Markus HS. Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001; 57:230710.
  • 10
    O'Sullivan M, Lythgoe DJ, Pereira AC et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002; 59:3216.
  • 11
    O'Sullivan M, Rich PM, Barrick TR, Clark CA, Markus HS. Frequency of subclinical lacunar infarcts in ischemic leukoaraiosis and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. AJNR Am J Neuroradiol 2003; 24:134854.
  • 12
    Pantoni L, Garcia J. Pathogenesis of leukoaraiosis. A review. Stroke 1997; 28:6529.
  • 13
    Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982; 32:8716.
  • 14
    Boiten J, Lodder J, Kessels F. Two clinically distinct lacunar infarct entities? A hypothesis. Stroke 1993; 24:6526.
  • 15
    Hassan A, Hunt BJ, O'Sullivan M et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126:42432.
  • 16
    Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34:80612.
  • 17
    Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002; 1:42636.
  • 18
    Charlton RA, Morris RG, Nitkunan A, Markus HS. The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology 2006; 66:15236.
  • 19
    O'Sullivan M, Morris RG, Markus HS. Brief cognitive assessment for patients with cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2005; 76:11405.
  • 20
    Dufouil C, Chalmers J, Coskun O et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic resonance imaging substudy. Circulation 2005; 112:164450.
  • 21
    Schmidt R, Scheltens P, Erkinjuntti T et al. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 2004; 63:13944.
  • 22
    Sabri O, Ringelstein EB, Hellwig D et al. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999; 30:55666.
  • 23
    de Groot JC, de Leeuw FE, Oudkerk M et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47:14551.
  • 24
    Wahlund LO, Almkvist O, Basun H, Julin P. MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life. Magn Reson Imaging 1996; 14:6018.
  • 25
    Taylor WD, MacFall JR, Provenzale JM et al. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors. AJR Am J Roentgenol 2003; 181:5716.
  • 26
    Garde E, Mortensen EL, Rostrup E, Paulson OB. Decline in inteliigence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 2005; 76:128991.
  • 27
    Cook IA, Leuchter AF, Morgan ML et al. Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry 2004; 12:190200.
  • 28
    Whitman GT, Tang Y, Lin A, Baloh RW. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001; 57:9904.
  • 29
    Schmidt R, Ropele S, Enzinger C et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005; 58:6106.
  • 30
    Hannesdottir K, Nitkunan A, Charlton RA, Barrick TR, Macgregor GA, Markus HS. Cognitive impairment and white matter damage in hypertension: a pilot study. Acta Neurol Scand 2009; 119:2618.
  • 31
    van den Heuvel DM, ten DV, de Craen AJ et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry 2006; 77:14953.
  • 32
    Wright CB, Festa JR, Paik MC et al. White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke 2008; 39:8005.
  • 33
    Carey CL, Kramer JH, Josephson SA et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2008; 39:397402.
  • 34
    O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004; 75:4417.
  • 35
    Gouw AA, van der Flier WM, Fazekas F et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008; 39:141420.
  • 36
    Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008; 39:19992005.
  • 37
    Chabriat H, Levy C, Taillia H et al. Patterns of MRI lesions in CADASIL. Neurology 1998; 51:4527.
  • 38
    Viswanathan A, Gschwendtner A, Guichard JP et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology 2007; 69:1729.
  • 39
    Holtmannspotter M, Peters N, Opherk C et al. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke 2005; 36:255965.
  • 40
    Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003; 361:20468.
  • 41
    Nitkunan A The use of quantitative magnetic resonance imaging techniques and neuropsychological tests to study cerebral small vessel disease. PhD thesis, St George's, University of London, London, UK, 2007.
  • 42
    Cook IA, Leuchter AF, Morgan ML et al. Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Arch Neurol 2002; 59:161220.
  • 43
    Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke 1986; 17:10907.
  • 44
    O'Sullivan M, Jones DK, Summers PE, Morris RG, Williams SC, Markus HS. Evidence for cortical “disconnection” as a mechanism of age-related cognitive decline. Neurology 2001; 57:6328.
  • 45
    Vermeer SE, Prins ND, den HT, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348:121522.
  • 46
    Gold G, Kovari E, Herrmann FR et al. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke 2005; 36:11848.
  • 47
    Benisty S, Gouw AA, Porcher R et al. Location of lacunar infarcts correlates with cognition in a sample of non disabled subjects with age-related white matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 2009; 80:47883.
  • 48
    Viswanathan A, Godin O, Jouvent E et al. Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging 2010; 31:162936.
  • 49
    Smith SM, Rao A, De Stefano N et al. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage 2007; 36:12006.
  • 50
    Christiansen P, Larsson HB, Thomsen C, Wieslander SB, Henriksen O. Age dependent white matter lesions and brain volume changes in healthy volunteers. Acta Radiol 1994; 35:11722.
  • 51
    Enzinger C, Fazekas F, Matthews PM et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 2005; 64:170411.
  • 52
    Liu RS, Lemieux L, Bell GS et al. A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage 2003; 20:2233.
  • 53
    Peters N, Holtmannspotter M, Opherk C et al. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology 2006; 66:151722.
  • 54
    Liem MK, Lesnik Oberstein SA, Haan J et al. MRI correlates of cognitive decline in CADASIL: a 7-year follow-up study. Neurology 2009; 72:1438.
  • 55
    Ikram MA, Vrooman HA, Vernooij MW et al. Brain tissue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging 2010; 31:37886.
  • 56
    Durand-Fardel M. Traite du ramollissement du creveau. Paris: Balliere, 1843.
  • 57
    van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van GJ. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991; 114:76174.
  • 58
    Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol 1998; 245:11622.
  • 59
    MacLullich AM, Wardlaw JM, Ferguson KJ, Starr JM, Seckl JR, Deary IJ. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry 2004; 75:151923.
  • 60
    Cumurciuc R, Guichard JP, Reizine D, Gray F, Bousser MG, Chabriat H. Dilation of Virchow-Robin spaces in CADASIL. Eur J Neurol 2006; 13:18790.
  • 61
    Werring DJ. Cerebral microbleeds: clinical and pathophysiological significance. J Neuroimaging 2007; 17:193203.
  • 62
    Greenberg SM, Vernooij MW, Cordonnier C et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8:16574.
  • 63
    Vernooij MW, Ikram MA, Wielopolski PA, Krestin GP, Breteler MM, van der LA. Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. Radiology 2008; 248:2727.
  • 64
    Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002; 33:153640.
  • 65
    Gregoire SM, Brown MM, Kallis C, Jager HR, Yousry TA, Werring DJ. MRI detection of new microbleeds in patients with ischemic stroke. Five-Year Cohort Follow-Up Study. Stroke 2010; 41:1846.
  • 66
    Soo YO, Yang SR, Lam WW et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol 2008; 255:167986.
  • 67
    Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999; 53:131927.
  • 68
    Vernooij MW, van der LA, Ikram MA et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008; 70:120814.
  • 69
    Viswanathan A, Guichard JP, Gschwendtner A et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain 2006; 129:237583.
  • 70
    Werring DJ, Frazer DW, Coward LJ et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004; 127:226575.
  • 71
    Jones DK, Lythgoe D, Horsfield MA, Simmons A, Williams SC, Markus HS. Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. Stroke 1999; 30:3937.
  • 72
    O'Sullivan M, Singhal S, Charlton R, Markus HS. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology 2004; 62:7027.
  • 73
    Chabriat H, Pappata S, Poupon C et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke 1999; 30:263743.
  • 74
    Schiavone F, Charlton RA, Barrick TR, Morris RG, Markus HS. Imaging age-related cognitive decline: a comparison of diffusion tensor and magnetization transfer MRI. J Magn Reson Imaging 2009; 29:2330.
  • 75
    Charlton RA, Barrick TR, McIntyre DJ et al. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 2006; 66:21722.
  • 76
    Schmidt R, Ropele S, Ferro J et al. Diffusion-weighted imaging and cognition in the Leukoariosis and Disability in the Elderly Study. Stroke 2010; 41:e4028.
  • 77
    Kleffner I, Deppe M, Mohammadi S et al. Diffusion tensor imaging demonstrates fiber impairment in Susac syndrome. Neurology 2008; 70:18679.
  • 78
    Della NR, Foresti S, Pratesi A et al. Whole-brain histogram and voxel-based analyses of diffusion tensor imaging in patients with leukoaraiosis: correlation with motor and cognitive impairment. AJNR Am J Neuroradiol 2007; 28:13139.
  • 79
    Charlton RA, Schiavone F, Barrick TR, Morris RG, Markus HS. Diffusion tensor imaging detects age-related white matter change over a two-year follow-up which is associated with working memory decline. J Neurol Neurosurg Psychiatry 2010; 81:139.
  • 80
    Nitkunan A, McIntyre DJ, Barrick TR et al. Correlations between MRS and DTI in cerebral small vessel disease. NMR Biomed 2006; 19:6106.
  • 81
    Nitkunan A, Charlton RA, McIntyre DJ, Barrick TR, Howe FA, Markus HS. Diffusion tensor imaging and MR spectroscopy in hypertension and presumed cerebral small vessel disease. Magn Reson Med 2008; 59:52834.
  • 82
    O'Sullivan M, Barrick TR, Morris RG, Clark CA, Markus HS. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology 2005; 65:158490.
  • 83
    Smith SM, Jenkinson M, Johansen-Berg H et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006; 31:1487505.
  • 84
    Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56:40715.
  • 85
    Iannucci G, Dichgans M, Rovaris M et al. Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2001; 32:6438.
  • 86
    Beaulieu C, Allen PS. Water diffusion in the giant axon of the squid: implications for diffusion-weighted MRI of the nervous system. Magn Reson.Med 1994; 32:57983.
  • 87
    Yao H, Sadoshima S, Kuwabara Y, Ichiya Y, Fujishima M. Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 1990; 21:16949.
  • 88
    De Reuck JL. Evidence for chronic ischaemia in the pathogenesis of vascular dementia: from neuroPATH to neuroPET. Acta Neurol Belg 1996; 96:22831.
  • 89
    Markus HS, Lythgoe DJ, Ostegaard L, O'Sullivan M, Williams SC. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 2000; 69:4853.
  • 90
    Chabriat H, Pappata S, Ostergaard L et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000; 31:190412.
  • 91
    Bastos-Leite AJ, Kuijer JP, Rombouts SA et al. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008; 29:1296301.
  • 92
    Brickman AM, Zahra A, Muraskin J et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res 2009; 172:11720.
  • 93
    Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2003; 74:706.
  • 94
    Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease – systematic review and meta-analysis. Neurobiol Aging 2009; 30:33752.
  • 95
    Wardlaw JM, Farrall A, Armitage PA et al. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke 2008; 39:132732.
  • 96
    Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal appearing white matter in patients with lacunar stroke and leukoaraiosis. J Neurol Neurosurg Psychiatry 2010; 81:1927.
  • 97
    Fazekas F, Ropele S, Schmidt R. Can small-vessel disease-related cerebral abnormalities be used as a surrogate marker for vascular dementia trials? J Neural Transm 2002; 62 (Suppl.): 617.
  • 98
    PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:103341.
  • 99
    Wiseman RM, Saxby BK, Burton EJ, Barber R, Ford GA, O'Brien JT. Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology 2004; 63:18927.